Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting

BACKGROUND: Vaccination that prevents tuberculosis (TB) disease, particularly in adolescents, would have the greatest impact on the global TB epidemic. Safety, reactogenicity and immunogenicity of the vaccine candidate M72/AS01(E) was evaluated in healthy, HIV-negative adolescents in a TB endemic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Penn-Nicholson, Adam, Geldenhuys, Hennie, Burny, Wivine, van der Most, Robbert, Day, Cheryl L., Jongert, Erik, Moris, Philippe, Hatherill, Mark, Ofori-Anyinam, Opokua, Hanekom, Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845829/
https://www.ncbi.nlm.nih.gov/pubmed/26072017
http://dx.doi.org/10.1016/j.vaccine.2015.05.088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845829/
https://www.ncbi.nlm.nih.gov/pubmed/26072017
http://dx.doi.org/10.1016/j.vaccine.2015.05.088

Ejemplares similares